To view this email as a web page, click here.
June 25, 2019
 
Psychiatric Pharmacogenomic Testing: The Evidence Base
Despite an impressive body of research literature, only four genes have been vetted as clinically actionable.
Image ©gopixa/Shutterstock.com

Read more
 
New Treatment Reduces Levels of Protein Linked to Huntington Disease
The first therapy to target the primary mechanism of the disease is safe and well tolerated, say study investigators.
Image ©MaltsevSemion/Shutterstock.com

Read more
ADVERTISEMENT

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.